Agenda - Workshop on Recombinant Protein-based COVID-19 Vaccines

Time	Speaker	Subject
9:00 AM – 9:05 AM	Peter Marks, CBER OD, FDA	Welcome Remarks
9:05 AM – 9:20 AM	Robert Johnson, BARDA	Pandemic preparedness, target product profile, timelines, and the need for continued investment
9:20 AM – 9:35 AM	Natalie Thornburg, CDC	Epidemiology, disease burden, continued need for COVID-19 vaccines
9:35 AM – 10:00 AM	John Beigel, NIH	Features of novel vaccines, need for next generation vaccines
10:00 AM – 10:20 AM	Presentation – Novavax, Inc. Filip Dubosky, Rick Crowley	Recombinant COVID-19 vaccines
10:20 AM – 10:40 AM	Presentation – Sanofi Roman Chicz	Recombinant COVID-19 vaccines
10:40 AM – 11:00 AM	Presentation – SK bioscience Harry Kleanthous	Recombinant COVID-19 vaccines
11:00 AM – 11:20 PM	Presentation – Dyadic Mark Emalfarb	Recombinant COVID-19 vaccines
11:20 AM – 11:40 AM	Presentation – Biological E, Limited Vikram Parakdar	Recombinant COVID-19 vaccines
11:40 AM – 12:00 PM	Presentation – Intravacc Dinja Oosterhoff	Recombinant COVID-19 vaccines
12:00 PM – 12:10 PM	Break	Break
12:10 PM – 12:55 PM	Frank Arnold, BARDA Jerry Weir, FDA Joel Straus, BIO Dave Robinson, BMGF Adam Hacker, CEPI	Panel Discussion Moderated by David Kaslow “Overcoming challenges to address strain updates and pandemic readiness”.
12:55 PM – 1:00 PM	David Kaslow	Closing